Welcome to the AD/PD™ 2022 Interactive Program
The conference will officially run on Central European Time (CET) - Barcelona Time
To convert the conference times to your local time Click Here
Session Description:
This symposium will introduce the need for new treatments for Alzheimer’s disease and Parkinson’s disease that go beyond symptomatic control and potentially treat the underlying causes of each disease. During this session, the pathophysiology of Alzheimer’s disease will be examined and drug targets other than amyloid and tau considered, including key data published on these targets to date. There will also be a presentation on neuroinflammation as an aspect of neurodegenerative diseases and a potential target for the treatment of both Alzheimer’s disease and Parkinson’s disease. Finally current treatments for Parkinson’s disease will be discussed briefly, as well as treatments currently being investigated in clinical trials, to provide a perspective on how the treatment landscape may change from symptomatic control to treatment in the future. These topics will be discussed by the expert faculty, who will also address any questions from attendees.